#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Thalassaemia alpha Essential thrombocythaemia Mucopolysaccharidosis I Cryoglobulinaemia Anti-neutrophil cytoplasmic antibody positive vasculitis Fallopian tube cancer Severe myoclonic epilepsy of infancy Corneal neovascularisation Liposarcoma Osteomyelitis Sickle cell anaemia IgA nephropathy Anaplastic large cell lymphoma T- and null-cell types Acute graft versus host disease in skin Nephroblastoma More trials…

    Learn about Rare Diseases

    Activated PI3 kinase delta syndrome – Trials in Disease Alport’s syndrome – Life with Disease Paroxysmal nocturnal haemoglobinuria – Treatment Acquired haemophilia Mitochondrial myopathy – Diagnostics Splenic marginal zone lymphoma – Diagnostics Andersen-Tawil syndrome – Basic Information Turner’s syndrome – Basic Information Shprintzen-Goldberg syndrome – Diagnostics Gaucher’s disease type III More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Amiloride Zilucoplan Sodium Rgx-202 Pf-06480605 Fidanacogene Elaparvovec Alternaria Alternata Extract COLESEVELAM HYDROCHLORIDE ARLOCABTAGENE AUTOLEUCEL Sisunatovir Aluminium Oxide Relebactam Ibrexafungerp Levosimendan AZD5148 Cetrimide Sodium Gluconate Tiemonium Methylsulphate Azithromycin Lasn01 Milademetan More therapies…

    Learn about Your Condition

    Breast cancer stage III Guttate psoriasis Bladder cancer stage III Agitation postoperative Myocarditis post infection Migraine with aura Herpes zoster Skin angiosarcoma Autoimmune uveitis Choroidal neovascularisation Hepatic encephalopathy Procedural headache Juvenile psoriatic arthritis Hypomagnesaemia Craniotomy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study of venetoclax and mercaptopurine combination treatment for patients with relapsed or treatment-resistant acute myeloid leukemia

    Not yet recruiting

    1 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Mercaptopurine
    • Venetoclax
    Belgium

  • Study on Dasatinib for Preventing Side Effects in Patients with Relapsed or Refractory Multiple Myeloma Receiving Idecabtagene Vicleucel Therapy

    Not yet recruiting

    1 1 1 1
    Investigated Diseases:
    • Cytokine release syndrome
    Investigated Drugs:
    • Idecabtagene Vicleucel
    • Dasatinib
    Germany

  • Study on the Safety of ATA-200 Gene Therapy for Patients with Limb-Girdle Muscular Dystrophy Type R5

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Muscular dystrophy
    Investigated Drugs:
    • Adeno-Associated Virus Serotype 8 Expressing The Human Gamma-Sarcoglycan Gene
    • Sirolimus
    • Abiraterone Acetate
    France Italy

  • Study Comparing Chemotherapy Alone to Dostarlimab, Paclitaxel, and Carboplatin for Patients with Advanced or Metastatic Endometrial Cancer

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Endometrial cancer
    Investigated Drugs:
    • Dostarlimab
    • Carboplatin
    • Paclitaxel
    France Italy Romania Spain

  • Study on CCTx-001, Cyclophosphamide Monohydrate, and Fludarabine Phosphate for Patients with Relapsed or Refractory Acute Myeloid Leukemia

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia recurrent
    • Acute myeloid leukaemia refractory
    Investigated Drugs:
    • Cctx-001
    • Cyclophosphamide Monohydrate
    • Fludarabine Phosphate
    France Germany Spain Sweden

  • Study of ALXN1850 for Children Aged 2 to 12 with Hypophosphatasia Who Have Not Previously Received Asfotase Alfa Treatment

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Hypophosphatasia
    Investigated Drugs:
    • Alxn1850
    Belgium Finland France Italy Poland Romania +2
Previous Page
1 … 869 870 871 872 873 … 1,674
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!